Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 05 - 06 tags : Treatment save search
Worldwide Tertiary Water and Wastewater Treatment Technologies Industry to 2027 - by Type, Application and Geography
Published: 2021-05-06 (Crawled : 17:00) - prnewswire.com
DD | News | $73.96 0.22% 0.0% 1.5M
|
Process Industries
|
| O: 0.06%
H: 0.65%
C: 0.53%
MMM | $92.02 -1.05% 0.0% 3.8M
|
Producer Manufacturing
|
| O: -0.08%
H: 0.61%
C: 0.56%
treatment application
Abbott Seeks Better Treatment Options for Patients with Both Atrial Fibrillation and Heart Failure with New Trial
Published: 2021-05-06 (Crawled : 14:00) - biospace.com/
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: -0.39%
H: 0.7%
C: 0.63%
treatment heart trial
GE Healthcare Acquires Zionexa; Molecular Imaging Agent Aims to Enable More Targeted Treatment for Metastatic Breast Cancer Patients
Published: 2021-05-06 (Crawled : 14:00) - biospace.com/
GE | News | $159.19 -2.11% 0.0% 10M
|
Electronic Technology
|
| O: 0.08%
H: 0.68%
C: -0.08%
treatment molecular cancer breast cancer imaging metastatic breast cancer
BIOSt® Nematicide Seed Treatment Reduces Greenhouse Gas Emissions in Soybeans and Corn by 85%+ Compared to Conventional Pesticides
Published: 2021-05-06 (Crawled : 13:00) - globenewswire.com
MBII | $0.7981 -20.19% 1.49%
|
Process Industries
|
| O: -0.6%
H: 2.4%
C: 1.2%
treatment pest
Aeterna Zentaris Announces the Selection of a Development Candidate in the DC-PTH Program for the Potential Treatment of Primary Hypoparathyroidism
Published: 2021-05-06 (Crawled : 12:15) - globenewswire.com
AEZS | $1.97 0.73% 6K
|
Health Technology
|
| O: -0.74%
H: 0.0%
C: -0.16%
treatment potential
Hepion Pharmaceuticals Completes Final Patient Recruitment in Phase 2a 'AMBITION' Clinical Trial of CRV431 for the Treatment of Advanced NASH
Published: 2021-05-06 (Crawled : 12:00) - globenewswire.com
HEPA | $1.39 -6.71% -7.19% 37K
|
Health Technology
|
| O: -1.23%
H: 1.86%
C: 0.62%
treatment phase 2 nash trial phase 2b crv431
Invizius Announces Successful Series A Financing to Develop Anti-Inflammatory Treatment for Haemodialysis
Published: 2021-05-06 (Crawled : 08:00) - prnewswire.com
ABCM | News | $23.99 0.0% 7.4M
|
Health Technology
|
| O: -1.62%
H: 1.31%
C: 0.68%
treatment
Antengene Announces Selinexor Added to Multiple Treatment Regimens in 2021 CSCO Guidelines
Published: 2021-05-06 (Crawled : 04:00) - prnewswire.com
KPTI | $1.1 0.92% 0.91% 1.2M
|
Health Technology
|
| O: 0.37%
H: 1.11%
C: 0.0%
treatment
MediciNova Receives a Notice of Intention to Grant for a New Patent Covering the Combination of MN-166 (ibudilast) and Riluzole for the Treatment of Amyotrophic Lateral Sclerosis (ALS) in Europe
Published: 2021-05-06 (Crawled : 01:00) - globenewswire.com
MNOV | $1.33 -3.73% 8K
|
Health Technology
|
| O: 2.35%
H: 0.23%
C: -8.05%
treatment europe sclerosis patent als mn-166 riluzole
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.